Takeda announces approval of moderna's covid-19 vaccine in japan

Osaka, japan--(business wire)--takeda pharmaceutical company limited (tse:4502/nyse:tak) (“takeda”) today announced that the ministry of health, labour and welfare (mhlw) granted special approval under article 14-3 of the pharmaceuticals and medical devices act for emergency use of moderna's mrna covid-19 vaccine, tak-919, now known as covid-19 vaccine moderna intramuscular injection, in japan. the approval is based on positive clinical data from takeda's phase 1/2 immunogenicity and safety cli
TAK Ratings Summary
TAK Quant Ranking